At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 50 target
Drug / intervention
25% intravenous (IV) sodium thiosulfatedrug
Likely dose
25% intravenous (IV) sodium thiosulfate 50 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Treatment Effect of Intravenous Sodium Thiosulfate on Coronary Calcification in Patients on Hemodialysis
In Brief
A Phase 2 clinical trial evaluating 25% intravenous (IV) sodium thiosulfate for Coronary Calcification and Vascular Calcification. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The present study will examine the treatment effect of sodium thiosulfate on coronary calcification in patients on hemodialysis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Calcification, Vascular Calcification
CountriesThailand
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2008
First PostedJul 2008
Primary CompletionMay 2009
Study CompletionNov 2009
TodayJul 2026
First PostedJul 23, 2008
Enrollment StartJul 1, 2008
Primary CompletionMay 1, 2009
Study CompletionNov 1, 2009
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 17.9 years ago
Interventions
25% intravenous (IV) sodium thiosulfatedrug
50 ml IV drip twice/week post hemodialysis